ArticleBMC cancer2024

Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06).

Sung Hee Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.